Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec;37(12):3089-3094.
doi: 10.1007/s10815-020-01984-3. Epub 2020 Oct 28.

Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation

P Rodrigues  1   2 , M Marques  1 , S Pimentel  1 , M Rato  1   2 , P Carvalho  1 , S C Correia  1 , N Mendes  1 , H Amaral  3 , J P Fernandes  3 , M J Carvalho  1 , C E Plancha  4   5
Affiliations
Case Reports

Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation

P Rodrigues et al. J Assist Reprod Genet. 2020 Dec.

Erratum in

Abstract

Purpose: This study aims to report a case of urgent fertility preservation in an oncological patient with collection of immature oocytes in the absence of ovarian stimulation that, through in vitro maturation (IVM), followed by ICSI and cryopreservation of zygotes resulted, 10 years later, in the live birth of a healthy baby.

Methods: In September 2008, our clinic performed IVM in a 32-year-old woman diagnosed with a ductal invasive carcinoma with positive estradiol receptors, negative progesterone receptors and positive human epidermal growth factor receptor 2. The retrieval of immature oocytes was performed in the absence of ovarian stimulation after a simple mastectomy and prior to any chemotherapy treatment. The compact cumulus-oocyte complexes (COCs) collected were placed in Lag medium for 2 h, followed by incubation in IVM medium, supplemented with heat inactivated patient serum, recombinant FSH, and recombinant LH. After 30 h in culture, cumulus cells were removed, the metaphase II oocytes were microinjected, and the zygotes obtained were cryopreserved. In 2017, the zygotes were thawed and cultured until day 3. One embryo was transferred and the other cryopreserved.

Results: Four compact COCs were collected and subjected to IVM. Two oocytes reached metaphase II and were microinjected. Two zygotes were obtained and were cryopreserved at the two pronuclear stage. Approximately 9 years later, the two zygotes were thawed and cultured until day 3. An embryo with 10 cells was transferred and implanted, resulting in the birth of a healthy baby.

Conclusions: In cases where urgency to start adjuvant therapy requires immediate oocyte collection, IVM may be the only option to obtain fully competent mature oocytes allowing for effective preservation of the reproductive potential.

Keywords: Controlled ovarian stimulation; Fertility preservation; Gonadotoxicity; Oncofertility; Oocyte in vitro maturation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Resume of clinical medical history and procedures
Fig. 2
Fig. 2
COCs placed in IVM (a), two MII oocytes recovered 30 h afterwards (b), were microinjected (c), and the following day zygotes were cryopreserved (d). Scale bars 50 μm
Fig. 3
Fig. 3
Embryo development post-thawing: (a) zygote post-thawing; (b) 4-cell embryo on day 2 of development; (c) 10-cell embryo on day 3, transferred embryo; and (d) 6-cell embryo on day 3, vitrified embryo on day 4. Scale bar 50 μm
See this image and copyright information in PMC

References

    1. Kitano A, et al. Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists. ESMO Open. 2019;4(2):1–8. doi: 10.1136/esmoopen-2018-000459. - DOI - PMC - PubMed
    1. Tammiste T, et al. A case report and follow-up of the first live birth after heterotopic transplantation of cryopreserved ovarian tissue in Eastern Europe. BMC Womens Health. 2019;19(1):1–8. doi: 10.1186/s12905-019-0764-8. - DOI - PMC - PubMed
    1. Son W-Y, Henderson S, Cohen Y, Dahan M, Buckett W. Immature oocyte for fertility preservation. Front Endocrinol (Lausanne) 2019;10(July):1–11. doi: 10.3389/fendo.2019.00464. - DOI - PMC - PubMed
    1. Garrido-Marín M, Argacha PM, Fernández L, Molfino F, Martínez-Soler F, Tortosa A, Gimenez-Bonafé P. Full-term pregnancy in breast cancer survivor with fertility preservation: A case report and review of literature. World J Clin Cases. 2019;7(1):58–68. doi: 10.12998/wjcc.v7.i1.58. - DOI - PMC - PubMed
    1. Grynberg M, Poulain M, Le Parco S, Sifer C, Fanchin R, Frydman N. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. Hum Reprod. 2016;31(3):623–629. doi: 10.1093/humrep/dev325. - DOI - PubMed

Publication types